MRC Impact Accelerator Accounts (Previously Confidence in Concept)
The tropical Infectious Disease Consortium (TIDC) has been awarded £1.6 million from the Medical Research Council (MRC) via the Impact Acceleration Account (IAA), previously Confidence in Concept (CiC). The TIDC is a strategic partnership between Liverpool School of Tropical Medicine (LSTM), UK Health Security Agency, London school of Hygiene & Tropical Medicine (LSHTM), the University of Oxford and has been expanded for this call to include the Science and Technology Facilities Council (STFC) and the Pirbright Institute. The TIDC has been awarded £1.6million over 3 years and represents the largest award to date. The award will allow the Consortium to support pump-priming projects, typically in the range of £50K, with the overreaching ambition to accelerate the transition from discovery science into therapeutic, diagnostic and vaccine development.